Yes. Orlistat tablets are considered standard medication and can be carried in your hand luggage. Keep them in their original packaging with a prescription label if possible, and declare them if requested by security personnel.
Both strengths work by the same mechanism. The 120 mg tablet provides a stronger lipase-inhibiting effect per dose, which is why it is the prescription strength in the UK. The 60 mg tablet is often used by individuals who prefer a lower dose or have milder weight-loss goals, but it may require stricter adherence to a low-fat diet to achieve comparable results.
Orlistat should only be taken with meals that contain a noticeable amount of fat (about 15-30 g). If you skip a meal or have a very low-fat meal, simply omit the dose for that time. Taking a tablet without fat increases the likelihood of unpleasant gastrointestinal side effects without providing benefit.
By reducing the absorption of dietary fat, Orlistat can lead to modest decreases in total cholesterol and low-density lipoprotein (LDL) levels. However, the primary purpose of the medication is weight reduction; any cholesterol change should be interpreted alongside dietary modifications and other risk-factors.
Yes. Because Orlistat reduces the absorption of fat-soluble vitamins and some hormones, it may slightly lower the effectiveness of estrogen-based contraceptives. Using a backup non-hormonal method (e.g., condom) is advisable while taking Orlistat.
You may experience the typical gastrointestinal side effects without any therapeutic benefit. No specific medical action is required unless the symptoms are severe; simply hydrate well and resume the normal dosing schedule with the next appropriate meal.
Yes, long-term use of Orlistat can diminish absorption of vitamins A, D, E, and K. A standard multivitamin taken at bedtime, at least 2 hours after the last Orlistat dose, minimizes any interaction.
Combining Orlistat with other over-the-counter weight-loss products is not recommended without medical supervision. Additional agents may have overlapping mechanisms or increase the risk of gastrointestinal discomfort and nutrient deficiencies.
Orlistat works locally in the gut and does not affect the central nervous system. It does not cause drowsiness or impair driving, although severe abdominal cramping could temporarily distract you.
Orlistat is a prescription-only medication in the United Kingdom used to aid weight loss in adults with a body mass index (BMI) of 28 kg/m² or higher, or a BMI ≥ 30 kg/m² when accompanied by weight-related health risks. It is available in pill form in two strengths: 60 mg (often sold over-the-counter) and 120 mg (prescribed). The active ingredient is Orlistat, a lipase-inhibiting agent that reduces the absorption of dietary fat.
Orlistat is marketed under several brand names, including Xenical (120 mg) and Alli (60 mg). In the UK, the 120 mg tablet is available on prescription, while the 60 mg tablet can be purchased without a prescription in some pharmacies.
Orlistat exerts its effect by inhibiting gastrointestinal lipases-the enzymes produced by the pancreas and gastric lining that normally break down dietary triglycerides into absorbable free fatty acids and monoglycerides. By blocking these enzymes, Orlistat prevents about 30 % of dietary fat from being hydrolyzed and absorbed. The un-digested fat is then excreted unchanged in the stool.
Key points of its pharmacology:
By reducing caloric intake from fat, Orlistat creates a negative energy balance that supports weight loss when combined with a reduced-calorie, nutritionally balanced diet and regular physical activity.
Orlistat is not approved for use in children or adolescents in the UK, and its efficacy in those groups has not been established.
Current peer-reviewed evidence does not support routine off-label use of Orlistat for conditions beyond weight management. Any non-approved application should only be considered under specialist supervision, with a clear risk-benefit assessment.
Ideal candidates
Absolute contraindications
Relative contraindications
Special populations
If any of the above conditions apply, discuss alternatives with a healthcare professional.
These effects are generally dose-related and tend to diminish as the patient adopts a lower-fat diet.
Note: Patients should inform their healthcare provider of all medicines, vitamins, herbal products, and supplements before starting Orlistat.
Regular follow-up ensures that weight loss is progressing safely and that nutrient deficiencies are prevented.
If the product becomes discoloured, smells unusual, or the packaging is damaged, discard it according to local pharmacy guidelines.
This article provides educational information about Orlistat and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
